Discontinued — last reported Q3 '22
Quanta Services Acquisitions increased by 6.0% to $1.27B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5858.5%, from $21.30M to $1.27B. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 5.6% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.33M | $33.26M | $2.35B | $0.00 | $4.81M | $172.96M | $17.32M | $452.25M | $0.00 | $20.39M | $178.98M | $384.07M | $66.73M | $1.27B | $21.30M | $394.26M | $191.84M | $1.20B | $1.27B |
| QoQ Change | — | -5.9% | >999% | -100.0% | — | >999% | -90.0% | >999% | -100.0% | — | +777.7% | +114.6% | -82.6% | >999% | -98.3% | >999% | -51.3% | +524.0% | +6.0% |
| YoY Change | — | — | — | — | -86.4% | +420.0% | -99.3% | — | -100.0% | -88.2% | +933.3% | -15.1% | — | >999% | -88.1% | +2.7% | +187.5% | -6.0% | >999% |